These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28173920)

  • 1. Split doses of Methotrexate in patients with moderate to severe Psoriasis.
    Rodríguez-Zúñiga MJM; Cortez-Franco F; Qujiano-Gomero E
    Actas Dermosifiliogr; 2017; 108(6):603-604. PubMed ID: 28173920
    [No Abstract]   [Full Text] [Related]  

  • 2. Clearance in psoriasis treatment.
    Kumar B; Saraswat A
    J Am Acad Dermatol; 2001 Jul; 45(1):153-4. PubMed ID: 11423858
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful use of infliximab as first line treatment for severe childhood generalized pustular psoriasis.
    Tsang V; Dvorakova V; Enright F; Murphy M; Gleeson C
    J Eur Acad Dermatol Venereol; 2016 Nov; 30(11):e117-e119. PubMed ID: 26403378
    [No Abstract]   [Full Text] [Related]  

  • 4. Methotrexate versus hydroxycarbamide (hydroxyurea) as a weekly dose to treat moderate-to-severe chronic plaque psoriasis: a comparative study.
    Ranjan N; Sharma NL; Shanker V; Mahajan VK; Tegta GR
    J Dermatolog Treat; 2007; 18(5):295-300. PubMed ID: 17852635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate with methotrexate: big benefit, questionable cost.
    Brownell I; Strober BE
    Br J Dermatol; 2007 Jul; 157(1):213. PubMed ID: 17578449
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of self-administered subcutaneous methotrexate for the treatment of psoriasis.
    Chiaravalloti AJ; Strober BE
    J Drugs Dermatol; 2014 Aug; 13(8):929-31. PubMed ID: 25116970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The METOP Study: Further Evidence for the Use of Subcutaneous Methotrexate in Psoriasis.
    Morgado-Carrasco D; Fustà-Novell X; Riera Monroig J; Mascaró Galy JM
    Actas Dermosifiliogr; 2017 Nov; 108(9):865-866. PubMed ID: 28583269
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomized controlled trial of methotrexate and cyclosporine in the treatment of psoriasis.
    Bigby M
    Arch Dermatol; 2004 Mar; 140(3):347-8. PubMed ID: 15023778
    [No Abstract]   [Full Text] [Related]  

  • 9. [Methotrexate in psoriasis: do we need to give a test dose?].
    Carretero-Hernández G
    Actas Dermosifiliogr; 2012; 103(1):1-4. PubMed ID: 22093543
    [No Abstract]   [Full Text] [Related]  

  • 10. The objective Psoriasis Area and Severity Index: a randomized controlled pilot study comparing the effectiveness of ciclosporin and methotrexate.
    Choi CW; Kim BR; Seo E; Youn SW
    Br J Dermatol; 2017 Dec; 177(6):1740-1741. PubMed ID: 28129675
    [No Abstract]   [Full Text] [Related]  

  • 11. Addition of low-dose methotrexate to infliximab in the treatment of a patient with severe, recalcitrant pustular psoriasis.
    Barland C; Kerdel FA
    Arch Dermatol; 2003 Jul; 139(7):949-50. PubMed ID: 12873907
    [No Abstract]   [Full Text] [Related]  

  • 12. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate-betamethasone weekly oral pulse in psoriasis.
    Gupta R; Gupta S
    J Dermatolog Treat; 2007; 18(5):291-4. PubMed ID: 17852636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate for generalized pustular psoriasis in a 2-year-old child.
    Dogra S; Kumaran MS; Handa S; Kanwar AJ
    Pediatr Dermatol; 2005; 22(1):85-6. PubMed ID: 15660909
    [No Abstract]   [Full Text] [Related]  

  • 15. Adherence of self-administered subcutaneous methotrexate in patients with chronic plaque-type psoriasis.
    Vidal D; Salleras M; Romaní J; Ribera M; Gallardo F; Viñas M; Xifra A; García-Navarro X; Bordas X; Ferran M; Carrascosa JM
    J Eur Acad Dermatol Venereol; 2016 Nov; 30(11):e131-e132. PubMed ID: 26446358
    [No Abstract]   [Full Text] [Related]  

  • 16. Psoriasis: the new and the old.
    Feldman SR
    J Drugs Dermatol; 2014 Aug; 13(8):894. PubMed ID: 25116962
    [No Abstract]   [Full Text] [Related]  

  • 17. [Update on psoriasis at the Dermatology Day conference, Paris 2010].
    Battistella M; Boulinguez S
    Ann Dermatol Venereol; 2011 Apr; 138(2 Suppl 2):H1-10. PubMed ID: 21703456
    [No Abstract]   [Full Text] [Related]  

  • 18. Methotrexate, a drug for the years to come.
    Naldi L; Saunes M
    Br J Dermatol; 2011 Aug; 165(2):230-1. PubMed ID: 21777212
    [No Abstract]   [Full Text] [Related]  

  • 19. Transition to ustekinumab in patients with moderate-to-severe psoriasis and inadequate response to methotrexate: a randomized clinical trial (TRANSIT).
    Paul C; Puig L; Kragballe K; Luger T; Lambert J; Chimenti S; Girolomoni G; Nicolas JF; Rizova E; Lavie F; Mistry S; Bergmans P; Barker J; Reich K;
    Br J Dermatol; 2014 Feb; 170(2):425-34. PubMed ID: 24116959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1).
    Barker J; Hoffmann M; Wozel G; Ortonne JP; Zheng H; van Hoogstraten H; Reich K
    Br J Dermatol; 2011 Nov; 165(5):1109-17. PubMed ID: 21910713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.